ASML vs NRDY

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

NRDY exhibits critical financial weakness, highlighted by a Piotroski F-Score of 1/9, indicating severe deterioration in fundamental health. While the company maintains a strong current ratio (2.27) and healthy gross margins (62.31%), these are offset by a devastating ROE of -135.37% and stagnant revenue growth of only 2.30% YoY. The combination of a bearish technical trend, heavy insider selling, and a 91.4% five-year price collapse suggests a failing growth thesis. Despite beating earnings estimates, the company remains deeply unprofitable with no clear path to positive net income.